Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05114096 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Single Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS)

Study acronym: SNACS
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 24 to 25v16
  2. Site details revised at 2 of 24 sitesv15
  3. Site details revised at 3 of 24 sitesv14
  4. Study sites: 41 to 24v13
  5. Site details revised at 2 of 41 sitesv12
Show 10 earlier versionsHide 10 earlier versions
  1. Site details revised at 1 of 41 sitesv11
  2. Site details revised at 1 of 41 sitesv10
  3. Trial status: Active, Not Recruiting to Recruiting Site details revised at 41 of 41 sitesv9 Show 1 more changeShow less
    • Site details revised at 41 of 41 sites
  4. Trial status: Recruiting to Active, Not Recruiting Study sites revised (41)v8 Show 1 more changeShow less
    • Study sites revised (41)

    See this version in full on ClinicalTrials.gov ↗

  5. Site contacts updated at 1 of 41 sitesv7
  6. Site details revised at 1 of 41 sitesv6
  7. Eligibility criteria shortened, about 23 words Study description expanded, about 23 wordsv5 Show 1 more changeShow less
    • Study description expanded, about 23 words

    See this version in full on ClinicalTrials.gov ↗

  8. Trial status: Not Yet Recruiting to Recruiting Primary completion date: Jun 30, 2026 to Dec 31, 2026 · Completion date: Jun 30, 2029 to Dec 31, 2029 · Start date changed from estimate of May 31, 2023 to Jul 20, 2023 · 5 morev4 Show 8 more changesShow less
    • Primary completion date: Jun 30, 2026 to Dec 31, 2026
    • Completion date: Jun 30, 2029 to Dec 31, 2029
    • Start date changed from estimate of May 31, 2023 to Jul 20, 2023
    • Secondary endpoints: 2 to 1
    • Study description expanded, about 38 words
    • Site details revised at 41 of 41 sites
    • Collaborators: 3 to 6
    • Eligibility criteria shortened, about 2 words

    See this version in full on ClinicalTrials.gov ↗

  9. Primary completion date: Jun 30, 2025 to Jun 30, 2026 Start date: Dec 15, 2022 to May 31, 2023 · Completion date: Jun 30, 2028 to Jun 30, 2029v3 Show 2 more changesShow less
    • Start date: Dec 15, 2022 to May 31, 2023
    • Completion date: Jun 30, 2028 to Jun 30, 2029
  10. Lead sponsor: Hamilton Health Sciences Corporation to McMaster University Start date: Dec 20, 2021 to Dec 15, 2022 · Collaborators: 2 to 3v2 Show 2 more changesShow less
    • Start date: Dec 20, 2021 to Dec 15, 2022
    • Collaborators: 2 to 3

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Antenatal corticosteroids (ACS) reduce the risks of neonatal death and morbidities in preterm infants, such as respiratory distress syndrome. The standard of care for pregnant people at risk of preterm birth includes 2 doses of Celestone (for a total of 24 mg in Canada, or 22.8 mg in Australia) to accelerate fetal lung maturity. The investigators plan to conduct a randomized controlled trial to determine whether half the usual dose (12 mg in Canada, or 11.4 mg in Australia) of Celestone is non-inferior to the standard double doses.
Trial Details
NCT Number NCT05114096
Lead Sponsor McMaster University
Collaborators: Hamilton Health Sciences Corporation, Sunnybrook Research Institute, Women's and Children's Hospital, Australia, Canadian Institutes of Health Research (CIHR), Medical Research Future Fund, University of Adelaide
Conditions Preterm Birth, Premature Birth, Complication of Prematurity, Obstetric Labor, Premature, Pregnancy Complications
Enrollment 3,254 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov